MAPT and Alzheimer disease: AD pathology is traditionally characterized by increased amyloid‐β (Aβ) plaque deposits and hyper‐phosphorylated Tau Tangle (Tau) development that are associated with worsening cognitive function (Morris et al., 2014; Zhang et al., 2011).